ERBB2 and breast cancer: This study comprised 682 controls (women without BC) and 267 treatment-naïve women with recently diagnosed BC: 157 had Luminal A, 41 Luminal B, 22 HER2-positive, and 47 had triple-negative BC (TNBC).